Where do we stand with mCRPC?

PARPi combinations to treat patients with mCRPC

Induction chemotherapy added to chemoradiation improves PFS and OS in advanced cervical cancer

Active surveillance for oesophageal cancer shows improved HRQoL compared to standard surgery

Sotorasib and panitumumab demonstrate clinically meaningful benefit in KRAS G12C-mutated metastatic colorectal cancer 

Genomic testing: Awareness and effective communication between healthcare professionals and patients

ESMO 2023: Latest in EGFR Ex20ins advanced NSCLC

Adagrasib shows durable clinical benefit in advanced KRAS-mutant NSCLC

Cost-benefit analysis of new cancer medicines: The difficult choices of governments

Short-course radiation as effective as standard treatment for breast cancer patients choosing reconstruction after mastectomy

Epitope editing enables targeted immunotherapy of acute myeloid leukaemia

OncoAlert Round Up for September 22-28, 2023